TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 81552290014

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81552290014 and manufactured by QINGDAO HIGHTOP BIOTECH CO.,LTD.. The registration is held by SETTY ASSESSORIA E CONSULTORIA EM ASSUNTOS REGULATORIOS LTDA with validity until Mar 18, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.